NEW YORK (GenomeWeb News) – The National Cancer Institute will serve as a coordinating center for the Centers for Disease Control and Prevention's Human Genome Epidemiology Network (HuGENet), a global collaboration aimed at studying how human genomic variation affects population health and how genetics can be used to combat disease and improve health.
HuGENet, which is run through the CDC's National Office of Public Health Genomics, has several primary functions linking genomics and disease research.
The network promotes knowledge synthesis by developing a cancer genetics database, explores epigenetics and gene/environment interactions, bolsters translational genomics research, and provides support for more than 30 epidemiological consortia.
The program also is tasked with coordinating comparative effectiveness research in genomics, supporting the Genomic Applications in Practice and Prevention (GAPPNet) program, and facilitating training and education in genomics.
NCI's Division of Cancer Control and Population Sciences will be one of six coordinating centers for HuGENet. The others include the National Office of Public Health Genomics; the HuGENet UK Coordinating Center in Cambridge; the University of Ioannina in Greece; the University of Ottawa in Canada; and Erasmus University in the Netherlands.